首页 | 本学科首页   官方微博 | 高级检索  
     

α1受体阻滞剂治疗良性前列腺增生合并高血压研究进展
引用本文:杨明根,赵晓昆. α1受体阻滞剂治疗良性前列腺增生合并高血压研究进展[J]. 中华男科学杂志, 2007, 13(9): 830-834
作者姓名:杨明根  赵晓昆
作者单位:中南大学湘雅二医院泌尿外科,湖南,长沙,410011
摘    要:流行病学调查提示原发性高血压是BPH发生和进展的独立危险因素之一,60岁以上的老年男性中25%同时患有BPH和高血压,严重影响着老年人的生活质量。关于BPH合并高血压的合理治疗方案,目前国内外的文献资料甚少,而且存在很大的争议。现对α1受体阻滞剂治疗BPH合并高血压的研究进展作一综述,分析其疗效,探讨其目前所面临的主要问题及可能的原因,并对其发展前景予以展望。

关 键 词:良性前列腺增生  高血压  α1受体阻滞剂
文章编号:1009-3591(2007)09-0830-05
收稿时间:2006-11-21
修稿时间:2007-04-02

Progress in the Studies of α1-Adrenoceptor Blocker for Concurrent Benign Prostatic Hyperplasia and Hypertension
YANG Ming-gen,ZHAO Xiao-kun. Progress in the Studies of α1-Adrenoceptor Blocker for Concurrent Benign Prostatic Hyperplasia and Hypertension[J]. National journal of andrology, 2007, 13(9): 830-834
Authors:YANG Ming-gen  ZHAO Xiao-kun
Affiliation:Department of Urology, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China
Abstract:The epidemiological survey shows that primary hypertension is one of the independent risk factors in the development and the progress of BPH, 25 percent of old male patients aged 60 or more suffer from the two diseases at the same time, which grievously affects their quality of life. There is little literature about the appropriate therapeutic regimen of BPH associated hypertension. The article reviews the progress in the studies of alpha1-adrenoceptor blocker for BPH associated hypertension, and explores the main problems facing us and ventures the prospects for the development in this field.
Keywords:benign prostatic hyperplasia  hypertension  α1-adrenoceptor blocker
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号